title: [Clostridium difficile infections - still a major challenge].
authors.affiliation: Medizinische Klinik I, Universitatsklinikum Erlangen. richard.strauss@uk-erlangen.de
authors.forename: R
authors.initials: R
authors.lastname: Strauss
authors.forename: M F
authors.initials: MF
authors.lastname: Neurath
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000472:pathogenicity; D003082:Colectomy; D003131:Combined Modality Therapy; D003428:Cross Infection / Q000175:diagnosis / Q000628:therapy; D018563:Disease Notification; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis* / Q000628:therapy; D000077732:Fidaxomicin; D008795:Metronidazole / Q000627:therapeutic use; D019936:Probiotics / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use; D014774:Virulence
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D008795:Metronidazole; D014640:Vancomycin; D000077732:Fidaxomicin